Search
for
Sort by
Research 631–660 of 1000+
- The Influence of 3% Hydrogen Peroxide on the Survival Rate of Hair Grafts When Used as an Antiseptic Solution for Surgical Wound Care: Experience with Five Patients
- TOC
- Review Article - Changing trends in hair restoration surgery
- NEW PROPRIETARY BRANDS: Gabapentin
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- NEW PROPRIETARY BRANDS: Cefaclor monohydrate
- NEW FORMULATIONS: Glatiramer acetate
- British Society for Dermatopathology: Summaries of Papers
- Allergens and Irritants
- Book Reviews
- Maryland Community Colleges Technology Needs Assessment Survey. Final Technical Report.
- Classified Advertising
- MOST IMPORTANT SKIN DISEASES OF CHILDRENTheir Diagnosis and Treatment
- Efficacy and safety of platelet rich plasma therapy in male androgenetic alopecia
- Evaluation of the effect of autologous platelet-rich plasma on androgenic alopecia
- Differential Diagnosis of Male and Female Pattern Hair Loss
- Instant Follicular Hair Unit Transplantation (IFHUT) in androgenetic alopecia – The evolving scenario
- Oral cyclosporin does not arrest progression of androgenetic alopecia
- Immunophenotypical analyses of myofibroblasts in rat excisional wound healing: possible transdifferentiation of blood vessel pericytes and perifollicular dermal sheath cells into myofibroblasts.
- The pivotal role of PDGF and its receptor isoforms in adipose-derived stem cells.
- Impacts of manipulating cell sorting on in vitro hair follicle regeneration
- Clinical and Laboratory Findings in Children with Hashimoto’s Thyroiditis
- Lymphoma Specialists Lament the Discontinuation of Underprescribed Bexxar
- İNSAN FƏALİYYƏTİ NƏTİCƏSİNDƏ SÜRÜNƏNLƏRİN SÜMÜK VƏ ƏZƏLƏ TOXUMASINDA YÜKSƏK TOKSİKİ TƏSİRLİ MİKROELEMENTLƏRİN TOPLANMASI
- 토마토 추출액 복합체가 전립선 암 세포와 전립선 비대증에 미치는 영향
- Oral Supplementation with l-Cystine, <i>Serenoa repens</i>, <i>Cucurbita pepo</i>, and <i>Pygeum africanum</i> in Chronic Telogen Effluvium and Androgenetic Alopecia: A Double-Blind, Placebo-Controlled, Randomized Clinical Study
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Thyroid Dysfunction and Women's Reproductive Health